FDA advisers discuss pediatric cancer meds

12/4/2012 | Bloomberg

A panel of FDA advisers is meeting to discuss testing four drugs with potential to treat childhood cancers. Relatively few children are affected by cancer, making robust clinical trial design difficult. The FDA requires drugmakers to study their products in children if that population is prone to the target disease, and new legislation taking effect next month will require those studies even earlier.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC